Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs.
about
Effects of Adoptive Transfer of Tolerogenic Dendritic Cells on Allograft Survival in Organ Transplantation Models: An Overview of Systematic ReviewsTransplantation tolerance and its outcome during infections and inflammationTempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cellsOrchestration of transplantation tolerance by regulatory dendritic cell therapy or in-situ targeting of dendritic cells.In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies.Generation and in vivo evaluation of IL10-treated dendritic cells in a nonhuman primate model of AAV-based gene transferDiversity of gut microflora is required for the generation of B cell with regulatory properties in a skin graft model.Donor bone marrow-derived dendritic cells prolong corneal allograft survival and promote an intragraft immunoregulatory milieu.Induction of transplantation tolerance through regulatory cells: from mice to men.Clinical management of patients receiving cell-based immunoregulatory therapy.Exploring cell-based tolerance strategies for hand and face transplantation.Constitutive expression of the anti-apoptotic Bcl-2 family member A1 in murine endothelial cells leads to transplant tolerance.Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation.Third-party tolerogenic dendritic cells reduce allo-reactivity in vitro and ameliorate the severity of acute graft-versus-host disease in allo-bone marrow transplantation.Update on Dendritic Cell-Induced Immunological and Clinical Tolerance.Harnessing Apoptotic Cells for Transplantation Tolerance: Current Status and Future Perspectives.Galectin-1 is required for the regulatory function of B cells.Effect of immune tolerance induced by immature dendritic cells and CTLA4-Ig on systemic lupus erythematosus: An in vivo study.Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NODRegulatory T cell-derived extracellular vesicles modify dendritic cell function.Human anti-pig NK cell and CD8+ T-cell responses in the presence of regulatory dendritic cells.March1-dependent modulation of donor MHC II on CD103 dendritic cells mitigates alloimmunity
P2860
Q26739998-7AD7A0E9-535B-4374-8586-4A326D1E38A5Q26829817-59ABE2C4-ABD4-48FE-AC90-369D58019DB5Q26851647-5779CCAE-64B7-4B40-A6F2-B19F8765B765Q34379951-7C9EF5D4-62E5-486F-A854-9B2D91DDCB96Q35184210-CE3FDA02-EA8C-4480-AE07-2957E04012D0Q35571114-36D85065-9B5B-4D33-ABCE-85902E643A05Q35673671-3811F41F-ADC2-4E16-B2CE-25631A7CCFD3Q37316849-4D7A0A57-8940-4244-A2C3-1A2779F5E73FQ38187170-DC71AF7A-2E8E-4B02-8B4A-3D00C9BD373FQ38201742-72DB83F2-A888-4309-BC6F-9D63189490C5Q38569715-A441C8E6-B4DC-4AE8-A87E-DFC5EF80E333Q40359260-0BAA31B3-1A94-4DD0-AC9B-2558DB90B192Q41045557-D9787737-8946-46B5-ADAD-8A5827570CFCQ45975551-772BF1A6-8AA1-4298-BE31-DAF9077783ABQ47121682-00CAA2D8-CB60-4575-8223-559723E9B33EQ47816665-D2AE870E-9E16-4FB5-BF28-D5B14AB06F28Q49318689-F9196C10-B00F-44BC-8A2E-311605D90BFDQ49875978-EB454203-E3B4-4D0F-98F5-EB8C70546693Q50350123-34B8A95B-098E-419B-8889-F48CD4D175ECQ52581960-EA5851D2-F017-4312-ABCD-46500C1471D7Q52836498-804B3C7A-940D-41F7-BB0B-9B90146BFD9CQ58699588-B1964AB8-B45D-4D31-982B-C572C07CE9ED
P2860
Tolerogenic Donor-Derived Dendritic Cells Risk Sensitization In Vivo owing to Processing and Presentation by Recipient APCs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tolerogenic Donor-Derived Dend ...... resentation by Recipient APCs.
@en
Tolerogenic Donor-Derived Dend ...... resentation by Recipient APCs.
@nl
type
label
Tolerogenic Donor-Derived Dend ...... resentation by Recipient APCs.
@en
Tolerogenic Donor-Derived Dend ...... resentation by Recipient APCs.
@nl
prefLabel
Tolerogenic Donor-Derived Dend ...... resentation by Recipient APCs.
@en
Tolerogenic Donor-Derived Dend ...... resentation by Recipient APCs.
@nl
P2093
P2860
P50
P356
P1476
Tolerogenic Donor-Derived Dend ...... Presentation by Recipient APCs
@en
P2093
Aurelie Moreau
Giovanna Lombardi
Kulachelvy Ratnasothy
Lesley A Smyth
Lucy Meader
Robert Lechler
Sally Alcock
P2860
P304
P356
10.4049/JIMMUNOL.1200870
P407
P577
2013-03-27T00:00:00Z